MedPharm Ltd

medpharm.co.uk

MedPharm is the leading specialist pharmaceutical development company, committed to the creation and development of topical and transdermal formulations for application to the skin, nail, mucous membranes, eye, nose and lung.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

LEXISNEXIS® REED TECH™ AND SCHLAFENDER HASE® ALLIANCE PROVIDES MUTUAL CUSTOMER BENEFITS FOR PHARMACEUTICAL AND MEDICAL DEVICE COMPANIES

LexisNexis Reed Tech | April 27, 2022

news image

Reed Technology and Information Services Inc. a leading provider of data management and analytics solutions for the life sciences industry, announced an alliance with Schlafender Hase®, the market leader for intelligent, automated proofreading software and services for regulated industries. Current and prospective customers of both companies can leverage exclusive benefits as part of this new alliance ecosystem. Pharmaceutical labelers who have regulatory deadlines for US FDA can benefit fro...

Read More

Business Insights

CATALENT TO ACQUIRE METRICS CONTRACT SERVICES FOR $475 MILLION TO EXPAND HIGH-POTENT CAPABILITIES AND ORAL DEVELOPMENT AND MANUFACTURING CAPACITY

Catalent, Inc. | August 10, 2022

news image

Catalent, Inc. the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it has reached an agreement to acquire Metrics Contract Services a full-service specialty Contract Development and Manufacturing Organization with a facility in Greenville, North Carolina, for $475 million from Mayne Pharma Group Limited. Upon completion, the acquisition will stre...

Read More

Pharma Tech

ANGELINI PHARMA SELECTS AIDEA’S ARTIFICIAL INTELLIGENCE TO BOOST ITS GROWTH

Angelini Pharma | March 11, 2021

news image

Trueblue, a main supplier of AI answers for Operational and Analytical CRM in the Life Science industry reports that Angelini Pharma, as a feature of a significant global computerized change measure, has picked AiDEA, the principal AI-Digital Cloud Pharma CRM arrangement dependent on Microsoft Dynamics 365. Angelini Pharma is a main pharmaceutical organization focused on aiding patients in the remedial zones of Central Nervous System (CNS) and Mental Health (including Pain), Rare Diseases and Co...

Read More

Pharma Tech

EUROPEAN MEDICINES AGENCY ACCEPTS ASTELLAS' MARKETING AUTHORIZATION APPLICATION FOR FEZOLINETANT

Astellas Pharma Inc. | September 30, 2022

news image

Astellas Pharma Inc. announced the European Medicines Agency has accepted for regulatory review the company's marketing authorization application for fezolinetant, an investigational oral, nonhormonal compound seeking approval for the treatment of moderate to severe vasomotor symptoms associated with menopause. VMS, characterized by hot flashes and/or night sweats, are common symptoms of menopause.1,2 "More than half of women 40 to 64 years of age ex...

Read More
news image

Business Insights

LEXISNEXIS® REED TECH™ AND SCHLAFENDER HASE® ALLIANCE PROVIDES MUTUAL CUSTOMER BENEFITS FOR PHARMACEUTICAL AND MEDICAL DEVICE COMPANIES

LexisNexis Reed Tech | April 27, 2022

Reed Technology and Information Services Inc. a leading provider of data management and analytics solutions for the life sciences industry, announced an alliance with Schlafender Hase®, the market leader for intelligent, automated proofreading software and services for regulated industries. Current and prospective customers of both companies can leverage exclusive benefits as part of this new alliance ecosystem. Pharmaceutical labelers who have regulatory deadlines for US FDA can benefit fro...

Read More
news image

Business Insights

CATALENT TO ACQUIRE METRICS CONTRACT SERVICES FOR $475 MILLION TO EXPAND HIGH-POTENT CAPABILITIES AND ORAL DEVELOPMENT AND MANUFACTURING CAPACITY

Catalent, Inc. | August 10, 2022

Catalent, Inc. the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it has reached an agreement to acquire Metrics Contract Services a full-service specialty Contract Development and Manufacturing Organization with a facility in Greenville, North Carolina, for $475 million from Mayne Pharma Group Limited. Upon completion, the acquisition will stre...

Read More
news image

Pharma Tech

ANGELINI PHARMA SELECTS AIDEA’S ARTIFICIAL INTELLIGENCE TO BOOST ITS GROWTH

Angelini Pharma | March 11, 2021

Trueblue, a main supplier of AI answers for Operational and Analytical CRM in the Life Science industry reports that Angelini Pharma, as a feature of a significant global computerized change measure, has picked AiDEA, the principal AI-Digital Cloud Pharma CRM arrangement dependent on Microsoft Dynamics 365. Angelini Pharma is a main pharmaceutical organization focused on aiding patients in the remedial zones of Central Nervous System (CNS) and Mental Health (including Pain), Rare Diseases and Co...

Read More
news image

Pharma Tech

EUROPEAN MEDICINES AGENCY ACCEPTS ASTELLAS' MARKETING AUTHORIZATION APPLICATION FOR FEZOLINETANT

Astellas Pharma Inc. | September 30, 2022

Astellas Pharma Inc. announced the European Medicines Agency has accepted for regulatory review the company's marketing authorization application for fezolinetant, an investigational oral, nonhormonal compound seeking approval for the treatment of moderate to severe vasomotor symptoms associated with menopause. VMS, characterized by hot flashes and/or night sweats, are common symptoms of menopause.1,2 "More than half of women 40 to 64 years of age ex...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us